According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy. © 2013 Landes Bioscience.
Todaro, M., Orlando, V., Cicero, G., Caccamo, N.R., Meraviglia, S., Stassi, G., et al. (2013). Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. ONCOIMMUNOLOGY, 2(9), 00-00 [10.4161/onci.25821].
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
TODARO, Matilde;CICERO, Giuseppe;CACCAMO, Nadia Rosalia;MERAVIGLIA, Serena;STASSI, Giorgio;DIELI, Francesco
2013-01-01
Abstract
According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy. © 2013 Landes Bioscience.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Todaro et al Oncoimmunology 2013.pdf
accesso aperto
Dimensione
195.45 kB
Formato
Adobe PDF
|
195.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
